1-9 of 9
Yi Tao
Close
Sort by
Journal Articles

FPN1, Targeted By Mir-17-5p, Regulates Cellular Iron Homeostasis Via activating Nrf2/Mir-17-5p/FPN1 Axis in Preclinical Model of Multiple Myeloma

Yuanyuan Kong, Shuaikang Chang, Liangning Hu, Gege Chen, Yi Tao, Yingcong Wang, Dandan Yu, Kang Lu, Yongsheng Xie, Wenxuan Bu, Jumei Shi, MD
Journal: Blood
Blood (2018) 132 (Supplement 1): 5616.
https://doi.org/10.1182/blood-2018-99-112230
Published: 2018
Journal Articles

Rafoxanide, an Organohalogen Drug, Triggers Apoptosis and Cell Cycle Arrest in Multiple Myeloma By Enhancing DNA Damage Responses and Suppressing the p38 MAPK Pathway

Jumei Shi, Wenqin Xiao, Zhijian Xu, Shuaikang Chang, Lu Gao, Yi Tao, Yingcong Wang, Xiaosong Wu, Weiliang Zhu
Journal: Blood
Blood (2018) 132 (Supplement 1): 5628.
https://doi.org/10.1182/blood-2018-99-113782
Published: 2018
Journal Articles

Carfilzomib Enhances Natural Killer Cell-Mediated Lysis of Myeloma Linked with Decreasing Expression of HLA Class I

Jumei Shi, MD, PhD, Guang Yang, Yuanyuan Kong, Minjie Gao, Yi Tao, Yiwen Zhang, Xiaosong Wu
Journal: Blood
Blood (2015) 126 (23): 1854.
https://doi.org/10.1182/blood.V126.23.1854.1854
Published: 2015
Journal Articles

Elevated Expression Of CKS1B Inhibits Senescence Thorough Enhanced Degradation Of p21 In Multiple Myeloma

Zhimin Gu, PhD, Yi Zhou, PhD, He Wang, MD, Ye Yang, PhD, Hongwei Xu, DDS, Junwei Huang, MD, Jie He, MD, Yi Tao, MD&PhD, Guido J. Tricot, M.D., Ph.D., Fenghuang Zhan, MD&PhD
Journal: Blood
Blood (2013) 122 (21): 1882.
https://doi.org/10.1182/blood.V122.21.1882.1882
Published: 2013
Journal Articles

RARα2 Expression Confers Myeloma Stem Cell Features

Guido J. Tricot, M.D., Ph.D., Ye Yang, PhD, Zhimin Gu, PhD, Hongwei Xu, DDS, Junwei Huang, MD, Jie He, MD, Yi Tao, MD&PhD, Fenghuang Zhan, MD&PhD
Journal: Blood
Blood (2013) 122 (21): 5404.
https://doi.org/10.1182/blood.V122.21.5404.5404
Published: 2013
Journal Articles

High Trip13 and Low P31 Comet Cause Drug Resistance and Poor Prognosis In Multiple Myeloma

Yi Tao, MD&PhD, Zhimin Gu, PhD, Ye Yang, PhD, Hongwei Xu, DDS, Xiaojing Hu, Guido J. Tricot, M.D., Ph.D., Fenghuang Zhan, MD&PhD, Jumei Shi, MD, PhD
Journal: Blood
Blood (2013) 122 (21): 3820.
https://doi.org/10.1182/blood.V122.21.3820.3820
Published: 2013
Journal Articles

Targeting BTK As a Treatment For Multiple Myeloma Stem Cells

Ye Yang, PhD, Zhimin Gu, PhD, Hongwei Xu, DDS, Junwei Huang, MD, Jie He, MD, Yi Tao, MD&PhD, Guido J. Tricot, M.D., Ph.D., Fenghuang Zhan, MD&PhD
Journal: Blood
Blood (2013) 122 (21): 271.
https://doi.org/10.1182/blood.V122.21.271.271
Published: 2013
Journal Articles

Valproic Acid Upregulates NKG2D Ligand Expression and Potentially Enhances Natural Killer Cell–mediated Cytolysis of Myeloma

Jumei Shi, MD, PhD, Yi Tao, Xiaosong Wu, Xiaojing Hu, Yang Shao, Jun Hou
Journal: Blood
Blood (2011) 118 (21): 5061.
https://doi.org/10.1182/blood.V118.21.5061.5061
Published: 2011
Journal Articles

TRAIL as the ATO-Target Gene Uniquely Activated In the Hyperdiploid Subtype of Myeloma with Prognostic Relevance, Resulting In Better Prognosis

Jumei Shi, MD, PhD, Jun Hou, Yi Tao, Xiuqin Meng, Ying Han, Maurizio Zangari, MD, Guido J. Tricot, MD, PhD, Fenghuang Zhan, MD, PhD
Journal: Blood
Blood (2010) 116 (21): 1904.
https://doi.org/10.1182/blood.V116.21.1904.1904
Published: 2010